Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Yissum Technology Transfer Company of the Hebrew University

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 6
Average round size
info
The average size of a deal this fund participated in
$5M
Portfolio companies 3
Rounds per year 0.11
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.50
Exits 1
Key employees Soon
Stages of investment
Early Stage Venture
Private Equity

Areas of investment

  • Biotechnology
  • Pharmaceutical
  • Health Care
  • Therapeutics
  • Biopharma
Summary

In 1964 was created Yissum Technology Transfer Company of the Hebrew University, which is appeared as Corporate Investor. The main department of described Corporate Investor is located in the Jerusalem. The fund was located in Asia if to be more exact in Israel.

Among the most popular fund investment industries, there are Pharmaceutical, Agriculture. For fund there is a match between the location of its establishment and the land of its numerous investments - Israel. Among the most popular portfolio startups of the fund, we may highlight Agrinnovate India, Avraham Pharmaceuticals, Avraham Pharmaceuticals. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. The fund has exact preference in a number of founders of portfolio startups.

The increased amount of exits for fund were in 2015. Considering the real fund results, this Corporate Investor is 3 percentage points less often commits exit comparing to other organizations. The fund is constantly included in less than 2 investment rounds annually. This Yissum Technology Transfer Company of the Hebrew University works on 12 percentage points less the average amount of lead investments comparing to the other organizations. Deals in the range of 5 - 10 millions dollars are the general things for fund. The top activity for fund was in 2013.

The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Yissum Technology Transfer Company of the Hebrew University, startups are often financed by Clal Biotechnology Industries, Technion Research & Development Foundation, Pontifax. The meaningful sponsors for the fund in investment in the same round are Clal Biotechnology Industries, Technion Research & Development Foundation, Pontifax. In the next rounds fund is usually obtained by Clal Biotechnology Industries, Technion Research & Development Foundation, Integra LifeSciences.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Yissum Technology Transfer Company of the Hebrew University:
Typical Co-investors
Yissum Technology Transfer Company of the Hebrew University is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Yissum Technology Transfer Company of the Hebrew University:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from Israel
Funds with similar focus located in Israel:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
ArlanWasHere Investments -
Bonduelle France, Provence-Alpes-Cote d'Azur, Villeneuve
Coulton Creek Capital Colorado, Greenwood Village, United States
Edison Capital Partners Luxembourg, Luxembourg
Extendam -
EY Startup Challenge England, London, United Kingdom
Instarto Central, Central Region, Singapore
Littlejohn & Co Connecticut, Greenwich, United States
LongLine Capital Beijing, Beijing, China
Pactolus Central, Central Region, Singapore
Prosper Women Entrepreneurs Missouri, St Louis, United States
SB Partners Seoul, Seoul-t'ukpyolsi, South Korea
Sino AG Düsseldorf, Germany, Nordrhein-Westfalen
Twangiza Transaction -
Varo Capital British Columbia, Canada, Vancouver
Venture Inc S.A. Dolnoslaskie, Poland, Wroclaw
Visa California, San Francisco, United States
Zag (BBH) England, London, United Kingdom

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Agrinnovate India

Agriculture
Education
Government
$4M26 Oct 2015 Delhi

Avraham Pharmaceuticals

Biotechnology
Health Care
Pharmaceutical
$9M13 Jul 2010 Israel, North District, Israel

Chiasma

Biopharma
Biotechnology
Therapeutics
$7M12 Sep 2005 Massachusetts, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Yissum Technology Transfer Company of the Hebrew University?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 6
Average round size 5M
Rounds per year 0.11
Peak activity year 2011
Lead investments 1
Follow on index 0.50
Exits 1
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Agrinnovate India

Agriculture
Education
Government
$4M26 Oct 2015 Delhi

Avraham Pharmaceuticals

Biotechnology
Health Care
Pharmaceutical
$9M13 Jul 2010 Israel, North District, Israel

Chiasma

Biopharma
Biotechnology
Therapeutics
$7M12 Sep 2005 Massachusetts, United States
Crunchbase icon

Content report

The following text will be sent to our editors: